Building BRICs of Pharma

The BRIC nations - comprised of Brazil, Russia, India and China -  are developing pharmaceutical markets that are comparable in size to many of their more mature Western counterparts. But in terms of the size of the opportunities for future growth, traditional markets are seemingly being dwarfed by the burgeoning behemoths of Brazil, Russia, India and China. Read the full story.